Tech Company Financing Transactions

Avrobio Funding Round

Atlas Accelerator, Clarus and SV Health Investors participated in a $25 million Series A funding round for Avrobio. The round was announced by the company on 8/3/2016.

Transaction Overview

Company Name
Announced On
8/3/2016
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors

Atlas Accelerator (Lead Investor) (Bruce Booth)

Clarus (Lead Investor) (Scott Requadt)

SV Health Investors (Lead Investor) (Joshua Resnick)

Proceeds Purpose
AVROBIO will use the proceeds from this financing to accelerate development of its clinical stage programs in Fabry disease and acute myeloid leukemia (AML), and to expand its pipeline in rare diseases and solid and liquid cancers.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. Building 300 201
Cambridge, MA 02139
USA
Email Address
Overview
AVROBIO is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. The catalyst for creating AVROBIO is to accelerate scientific breakthroughs related to the convergence of cell and gene therapies.
Profile
Avrobio LinkedIn Company Profile
Social Media
Avrobio Company Twitter Account
Company News
Avrobio News
Facebook
Avrobio on Facebook
YouTube
Avrobio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Geoff MacKay
  Geoff MacKay LinkedIn Profile  Geoff MacKay Twitter Account  Geoff MacKay News  Geoff MacKay on Facebook
Chief Scientific Officer
Chris Mason
  Chris Mason LinkedIn Profile  Chris Mason Twitter Account  Chris Mason News  Chris Mason on Facebook
Vice President
Kathryn McNaughton
  Kathryn McNaughton LinkedIn Profile  Kathryn McNaughton Twitter Account  Kathryn McNaughton News  Kathryn McNaughton on Facebook
VP - Bus. Development
Deanna Petersen
  Deanna Petersen LinkedIn Profile  Deanna Petersen Twitter Account  Deanna Petersen News  Deanna Petersen on Facebook
VP - Operations
Kim Warren
  Kim Warren LinkedIn Profile  Kim Warren Twitter Account  Kim Warren News  Kim Warren on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/3/2016: DISCO venture capital transaction
Next: 8/3/2016: TruRating venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary